{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:27:17Z","timestamp":1790792837938,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T00:00:00Z","timestamp":1649376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T00:00:00Z","timestamp":1649376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>To promote antimicrobial stewardship, we studied antimicrobial prescription rates for uncomplicated cystitis, a common outpatient disease requiring antibiotic treatment. This multicenter retrospective study was performed from January 1, 2018, to December 31, 2020, in Japan, targeting outpatients aged\u2009\u2265\u200920\u00a0years whose medical records revealed International Classification of Diseases (ICD-10) codes suggesting uncomplicated cystitis (N300). The data of 1445 patients were collected and that of 902 patients were analyzed. The overall median patient age was 71\u00a0years and a proportion of those aged less than 50\u00a0years was 18.8% with a female dominance (82.6%). Antimicrobials were prescribed for 884 patients (98.0%) and a total of 623 patients (69.1%) were treated with broad-spectrum drugs, including fluoroquinolones (36.0%), third-generation cephalosporins (29.9%) and faropenem (3.1%). A logistic regression model revealed that the broad-spectrum agents were significantly prescribed for the older patients, male patients, and those who visited internists. Recurrence was observed in 37 (4.1%) cases, and the multivariate analysis suggested any of age, sex, or antimicrobial types were not associated with the recurrence. Collectively, approximately two-thirds of antimicrobials prescribed for uncomplicated cystitis were broad-spectrum agents. The present data would be an indicator for antimicrobial prescriptions in uncomplicated cystitis in Japan.<\/jats:p>","DOI":"10.1038\/s41598-022-09946-8","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T06:07:06Z","timestamp":1649398026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Antimicrobial prescription practices for outpatients with uncomplicated cystitis in Japan"],"prefix":"10.1038","volume":"12","author":[{"given":"Misa","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideharu","family":"Hagiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Higashionna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Haruki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Haruki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,8]]},"reference":[{"key":"9946_CR1","unstructured":"World Health Organization. Global action plan on antimicrobial resistance. https:\/\/www.paho.org\/en\/documents\/global-action-plan-antimicrobial-resistance-2017 (2017)."},{"key":"9946_CR2","unstructured":"Japan Agency for Medical Research and Development. National action plan on antimicrobial resistance (AMR) 2016\u20132020. https:\/\/www.mhlw.go.jp\/file\/06-Seisakujouhou-10900000-Kenkoukyoku\/0000138942.pdf (2020)."},{"key":"9946_CR3","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2013: Annual report of the European antimicrobial resistance surveillance network (EARS-Net) https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/media\/en\/publications\/Publications\/antimicrobial-resistance-surveillance-europe-2013.pdf (2014)."},{"key":"9946_CR4","doi-asserted-by":"crossref","unstructured":"Geerlings, S. E. Clinical presentations and epidemiology of urinary tract infections. Microbiolgy Spectr. 4 (2016).","DOI":"10.1128\/microbiolspec.UTI-0002-2012"},{"issue":"Suppl 1A","key":"9946_CR5","doi-asserted-by":"publisher","first-page":"5S","DOI":"10.1016\/S0002-9343(02)01054-9","volume":"113","author":"B Foxman","year":"2002","unstructured":"Foxman, B. Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs. Am. J. Med. 113(Suppl 1A), 5S-13S (2002).","journal-title":"Am. J. Med."},{"key":"9946_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0924-8579(01)00303-X","volume":"17","author":"AR Ronald","year":"2001","unstructured":"Ronald, A. R. et al. Urinary tract infection in adults: Research priorities and strategies. Int. J. Antimicrob. Agents 17, 343\u2013348 (2001).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"9946_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.f3140","volume":"346","author":"K Gupta","year":"2013","unstructured":"Gupta, K. & Trautner, B. W. Diagnosis and management of recurrent urinary tract infections in non-pregnant women. BMJ 346, 1\u20136 (2013).","journal-title":"BMJ"},{"key":"9946_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/cid\/ciq257","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta, K. et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the infectious diseases society of America and the European society for microbiology and infectious diseases. Clin. Infect. Dis. 52, 103\u2013120 (2011).","journal-title":"Clin. Infect. Dis."},{"key":"9946_CR9","doi-asserted-by":"publisher","first-page":"e169","DOI":"10.1093\/cid\/ciaa1478","volume":"72","author":"PD Tamma","year":"2021","unstructured":"Tamma, P. D. et al. Infectious diseases society of America guidance on the treatment of extended-spectrum \u03b2-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa). Clin. Infect. Dis. 72, e169\u2013e183 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"9946_CR10","unstructured":"European Urological Association (EAU) guidelines on urological infections. http:\/\/www.uroweb.org\/gls\/pdf\/15_Urological_Infections.pdf (2020)."},{"key":"9946_CR11","first-page":"31","volume":"64","author":"S Yamamoto","year":"2017","unstructured":"Yamamoto, S. et al. Japanese association for infectious disease (JAID)\/ Japanese society of chemotherapy (JSC) guidelines for clinical management of infectious disease 2015 urinary tract infection\/male genital infection. J. Infect. Chemother. 64, 31\u201365 (2017).","journal-title":"J. Infect. Chemother."},{"key":"9946_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jiac.2020.09.001","volume":"27","author":"Y Kusama","year":"2021","unstructured":"Kusama, Y., Ishikane, M., Kihara, T. & Ohmagari, N. Epidemiology of antibiotic treatment for uncomplicated cystitis in adults in Japan. J. Infect. Chemother. 27, 113\u2013116 (2021).","journal-title":"J. Infect. Chemother."},{"key":"9946_CR13","unstructured":"Japan Nosocomial Infections Surveillance. Public information on nosocomial infection control surveillance laboratory 2007 annual report. https:\/\/janis.mhlw.go.jp\/report\/kensa.html (2008)."},{"key":"9946_CR14","unstructured":"Japan Nosocomial Infections Surveillance. Public information on nosocomial infection control surveillance laboratory 2020 annual report. https:\/\/janis.mhlw.go.jp\/report\/kensa.html (2021)."},{"key":"9946_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijid.2019.11.009","volume":"91","author":"H Hashimoto","year":"2020","unstructured":"Hashimoto, H. et al. Indications and classes of outpatient antibiotic prescriptions in Japan: A descriptive study using the national database of electronic health insurance claims, 2012\u20132015. Int. J. Infect. Dis. 91, 1\u20138 (2020).","journal-title":"Int. J. Infect. Dis."},{"key":"9946_CR16","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.molmed.2016.09.003","volume":"22","author":"LK McLellan","year":"2016","unstructured":"McLellan, L. K. & Hunstad, D. A. Urinary tract infection: Pathogenesis and outlook. Trends Mol. Med. 22, 946\u2013957 (2016).","journal-title":"Trends Mol. Med."},{"key":"9946_CR17","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1681\/ASN.2015030327","volume":"27","author":"PD Olson","year":"2016","unstructured":"Olson, P. D., Hruska, K. A. & Hunstad, D. A. Androgens enhance male urinary tract infection severity in a new model. J. Am. Soc. Nephrol. 27, 1625\u20131634 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"9946_CR18","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1097\/01.ju.0000155596.98780.82","volume":"173","author":"TL Griebling","year":"2005","unstructured":"Griebling, T. L. Urologic diseases in America project: Trends in resource use for urinary tract infections in women. J Urol. 173, 1281\u20131287 (2005).","journal-title":"J Urol."},{"key":"9946_CR19","doi-asserted-by":"crossref","unstructured":"Ingersoll, M. A. Sex differences shape the response to infectious diseases. PLoS Pathog. 13, e1006688 (2017).","DOI":"10.1371\/journal.ppat.1006688"},{"key":"9946_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/tre.8","volume":"12","author":"M Harper","year":"2007","unstructured":"Harper, M. & Fowlis, G. Management of urinary tract infections in men. Trends Urol. Gynecol. Sex. Heal. 12, 30\u201335 (2007).","journal-title":"Trends Urol. Gynecol. Sex. Heal."},{"key":"9946_CR21","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jiac.2017.07.011","volume":"23","author":"T Etani","year":"2017","unstructured":"Etani, T. et al. Antimicrobial susceptibility of pathogens in acute uncomplicated cystitis cases in the urology department of a community hospital in Japan: Comparison with treatment outcome and hospital-wide antibiogram. J. Infect. Chemother. 23, 692\u2013697 (2017).","journal-title":"J. Infect. Chemother."},{"key":"9946_CR22","doi-asserted-by":"crossref","unstructured":"Yan, K., Zhu, M., Jia, Y., Wang, J. & Cai, Y. Efficacy and safety of quinolones vs. other antimicrobials for the treatment of uncomplicated urinary tract infections in adults: A systematic review and meta-analysis. Int. Urogynecol. J. (2021).","DOI":"10.1007\/s00192-021-05013-4"},{"key":"9946_CR23","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cmi.2019.10.016","volume":"26","author":"N Daneman","year":"2020","unstructured":"Daneman, N. et al. Fluoroquinolone use for uncomplicated urinary tract infections in women: A retrospective cohort study. Clin. Microbiol. Infect. 26, 613\u2013618 (2020).","journal-title":"Clin. Microbiol. Infect."},{"key":"9946_CR24","unstructured":"Food and Drug Administration (FDA). FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. Drug Saf. Commun. 1\u20134 https:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM628757.pdf (2018)."},{"key":"9946_CR25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s10156-010-0174-1","volume":"17","author":"K Ishikawa","year":"2011","unstructured":"Ishikawa, K. et al. The nationwide study of bacterial pathogens associated with urinary tract infections conducted by the Japanese society of chemotherapy. J. Infect. Chemother. 17, 126\u2013138 (2011).","journal-title":"J. Infect. Chemother."},{"key":"9946_CR26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10156-013-0606-9","volume":"19","author":"H Hayami","year":"2013","unstructured":"Hayami, H. et al. Nationwide surveillance of bacterial pathogens from patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2009 and 2010: Antimicrobial susceptibility of Escherichia coli and Staphylococcus saprophyticus. J. Infect. Chemother. 19, 393\u2013403 (2013).","journal-title":"J. Infect. Chemother."},{"key":"9946_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ofid\/ofw159","volume":"3","author":"M Kobayashi","year":"2016","unstructured":"Kobayashi, M., Shapiro, D. J., Hersh, A. L., Sanchez, G. V. & Hicks, L. A. Outpatient antibiotic prescribing practices for uncomplicated urinary tract infection in women in the United states, 2002\u20132011. Open Forum Infect. Dis. 3, 1\u20137 (2016).","journal-title":"Open Forum Infect. Dis."},{"key":"9946_CR28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1136\/bmj.l525","volume":"364","author":"M Gharbi","year":"2019","unstructured":"Gharbi, M. et al. Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all cause mortality: Population based cohort study. BMJ 364, 525 (2019).","journal-title":"BMJ"},{"key":"9946_CR29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/02813432.2019.1569425","volume":"37","author":"A Holm","year":"2019","unstructured":"Holm, A., Cordoba, G. & Aabenhus, R. Prescription of antibiotics for urinary tract infection in general practice in Denmark. Scand. J. Prim. Health Care 37, 83\u201389 (2019).","journal-title":"Scand. J. Prim. Health Care"},{"key":"9946_CR30","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.ijantimicag.2019.06.015","volume":"54","author":"K Malmros","year":"2019","unstructured":"Malmros, K. et al. Comparison of antibiotic treatment guidelines for urinary tract infections in 15 European countries: Results of an online survey. Int. J. Antimicrob. Agents 54, 478\u2013486 (2019).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"9946_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jgar.2021.11.008","volume":"28","author":"F Wagenlehner","year":"2022","unstructured":"Wagenlehner, F. et al. A global perspective on improving patient care in uncomplicated urinary tract infection: Expert consensus and practical guidance. J. Glob. Antimicrob. Resist. 28, 18\u201329 (2022).","journal-title":"J. Glob. Antimicrob. Resist."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09946-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09946-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09946-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T20:40:39Z","timestamp":1669322439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09946-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,8]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["9946"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-09946-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,8]]},"assertion":[{"value":"2 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5921"}}